Our Mission
Our mission is to develop innovative treatments to improve the lives of individuals suffering from neuropsychiatric and neurologic disorders in order to reduce the burden on patients and their caregivers.
Pipeline & Products
From bench to bedside, a diverse portfolio of investigational compounds across different stages of drug development.
Leadership / Management Team
Industry professionals with extensive experience in discovery, development, and commercialization.
CAPLYTA is a trademark of Intra-Cellular Therapies, Inc.
US-CAP-2000372 6/20
© 2020 Intra-Cellular Therapies Inc. All rights reserved.